bone morphogenetic protein (BMP) signaling and accelerated chondrocytes differentiation. 8 Yang et al 9 found that TGF-β/SMAD3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. Based on these observations, TGF-β/ SMAD3 signaling plays an important role in the etiology of OA by regulating chondrocytes differentiation.
SMAD3 is located on chromosomes 15q21-22. van de Laar et al 10 revealed that mutations in SMAD3 could contribute to increased aortic expression of several key members in the TGF-β pathway including SMAD3, which showed significant correlation with early-onset OA. Recently, 5 studies (2 Caucasian studies and 3 Asian studies) explored the association between SMAD3 rs12901499 polymorphism and risk of OA, but with conflicting results. [11] [12] [13] [14] [15] Some studies have shown that SMAD3 rs12901499 polymorphism was associated with OA risk. 11, 12, 14 However, other studies have found no such association. 13 , 15 The aim of this study was to evaluate whether SMAD3 gene rs12901499 polymorphism conferred susceptibility to risk of knee OA in a Chinese population.
| PATIENTS AND METHODS

| Study population
All subjects including 350 knee patients with OA and 400 healthy con- 
| Genotyping
About 2 mL of peripheral blood from every subject was collected in the test tubes containing ethylene diamine tetraacetic acid (EDTA).
Genomic DNA was extracted from peripheral blood using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instruction. DNA samples were conducted the test of quality and concentration with ultraviolet spectrophotometer and stored at −20°C. Single-nucleotide polymorphism (SNP) genotyping was performed using a custom-by-design 48-Plex SNP scan ™ Kit (Genesky Biotechnologies Inc., Shanghai, China).
| Statistical analysis
The chi-squared test was used to assess differences in the demographic characteristics and variables of study population. The
Hardy-Weinberg equilibrium (HWE) was tested by a goodness-of-fit chi-squared test, to compare the observed and expected genotype frequencies among controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to estimate association between SMAD3 gene rs12901499 polymorphism and risk of knee OA using logistic regression analyses. All statistical analyses were performed using the SAS software package (ver. 9.1.3; SAS Institute, Cary, NC, USA).
P < .05 was considered to indicate a significant difference. Table 1 lists participant demographics and risk factors in knee OA.
| RESULTS
| Clinical parameters of the study population
The subjects were matched for age and sex (P = .711 and P = .811, respectively). The average body mass index (BMI) was 26.04 ± 3.32 kg/ m 2 , which was higher than that in the control group. The significant association was observed in the subgroup of BMI (P < .001). KellgrenLawrence grading was used to assess disease severity in the knee OA cases and controls. Patients with grade 2 account for the majority of cases.
| Association between SMAD3 gene rs12901499 polymorphism and knee OA risk
The genotyping frequencies of SMAD3 gene rs12901499 polymorphism in cases and controls are listed in Table 2 . The observed genotype frequencies in the controls were in line with the HWE (P = .534).
Our results revealed that SMAD3 rs12901499 polymorphism was associated with the decreased risk of knee OA (GG vs AA, OR, 0.66, 95%
CI, 0.44-0.99, P = .047). However, G allele of rs12901499 polymorphism exhibited negative association with the risk of knee OA. This negative association was also observed in the recessive (P = .167) and dominant (P = .066) models.
Stratified analysis by sex indicated that there was no significant association between SMAD3 rs12901499 polymorphism and risk of knee OA in the homozygous, dominant and recessive models (Table 3) .
Similarly, no significant association was observed in the subgroup analysis of age. Greek population regarding spinal degenerative OA. They did not find an association between rs12901499 polymorphism and spinal degenerative OA risk. 15 In this study, we found SMAD3 rs12901499 polymorphism was associated with decreased risk of knee OA. We only observed this significant association in the homozygous model (GG vs AA, OR 0.66, 95% CI, 0.44-0.99, P = .047). We also conducted subgroup analyses of age and sex and found no association with rs12901499 polymorphism. Obviously, the findings of all these studies were contradictory. Therefore, it is necessary to perform a comprehensive meta-analysis to examine these inconsistent results and clarify the associations between SMAD3 rs12901499 polymorphism and OA. However, we cannot extract the genotype numbers of cases and controls among Caucasian study by Valdes et al
| DISCUSSION
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Because we cannot combine the data of Asians and Caucasians, we think it is not time to conduct a meta-analysis. The association also needed to be confirmed in different ethnic groups with large sample sizes.
Some limitations of this case-control study should be taken into consideration. First, our results were based on unadjusted estimates, 
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